0QZU (0QZU): Results for Last 10 Financial Years (Summary)

Vertex Pharmaceuticals Incorporated

LSE (USD): Vertex Pharmaceuticals Incorporated (0QZU)

Last Price

443.41

Today's Change

+1.58 (0.35%)

Day's Change

438.98 - 444.98

Trading Volume

Financial

Market Cap

113 Billion

Shares Outstanding

256 Million

Latest Quarter

31-Mar-2025 [Q1]

Announcement Date

06-May-2025

Reported Currency

USD

Revenue QoQ | YoY

-4.87% | 3.09%

NP QoQ | YoY

-29.21% | -41.22%

Latest Audited

31-Dec-2024

Announcement Date

13-Feb-2025

Reported Currency

USD

Revenue | Net Profit

11,020,100,000.00 | -535,600,000.00

EPS | EPS Diluted

-2.08 Cent | -2.08 Cent

YoY

-114.80%

NP Margin

-4.86%

Reported Currency in USD

Show?

YoY %

Horiz. %

	31/12/24	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	CAGR
Last 10 FY Result (Thousand)
Revenue	11,020,100	9,869,200	8,930,700	7,574,400	6,205,683	4,162,821	3,047,597	2,488,652	1,702,177	1,032,336	30.06%
YoY %	11.66%	10.51%	17.91%	22.06%	49.07%	36.59%	22.46%	46.20%	64.89%	-	-
Horiz. %	1,067.49%	956.01%	865.10%	733.71%	601.13%	403.24%	295.21%	241.07%	164.89%	100.00%	-
PBT	248,500	4,379,800	4,232,400	2,730,400	3,116,900	1,394,919	600,241	-15,689	-67,366	-559,581	-
YoY %	-94.33%	3.48%	55.01%	-12.40%	123.45%	132.39%	3,925.87%	76.71%	87.96%	-	-
Horiz. %	-44.41%	-782.69%	-756.35%	-487.94%	-557.01%	-249.28%	-107.27%	2.80%	12.04%	100.00%	-
Tax	784,100	760,200	910,400	388,300	405,151	218,109	-1,486,862	-107,324	16,665	30,381	43.45%
YoY %	3.14%	-16.50%	134.46%	-4.16%	85.76%	114.67%	-1,285.40%	-744.01%	-45.15%	-	-
Horiz. %	2,580.89%	2,502.22%	2,996.61%	1,278.10%	1,333.57%	717.91%	-4,894.05%	-353.26%	54.85%	100.00%	-
NP	-535,600	3,619,600	3,322,000	2,342,100	2,711,700	1,176,810	2,096,896	263,484	-112,052	-558,115	-0.45%
YoY %	-114.80%	8.96%	41.84%	-13.63%	130.43%	-43.88%	695.83%	335.14%	79.92%	-	-
Horiz. %	95.97%	-648.54%	-595.22%	-419.64%	-485.87%	-210.85%	-375.71%	-47.21%	20.08%	100.00%	-
Tax Rate	-315.53%	-17.36%	-21.51%	-14.22%	-13.00%	-15.64%	247.71%	-	-	-	-
YoY %	-1,717.57%	19.29%	-51.27%	-9.38%	16.88%	-106.31%	0.00%	-	-	-	-
Horiz. %	-127.38%	-7.01%	-8.68%	-5.74%	-5.25%	-6.31%	100.00%	-	-	-	-
Total Cost	11,555,700	6,249,600	5,608,700	5,232,300	3,493,983	2,986,011	950,701	2,225,168	1,814,229	1,590,451	24.62%
YoY %	84.90%	11.43%	7.19%	49.75%	17.01%	214.09%	-57.28%	22.65%	14.07%	-	-
Horiz. %	726.57%	392.95%	352.65%	328.98%	219.69%	187.75%	59.78%	139.91%	114.07%	100.00%	-

	31/12/24	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	CAGR
Ratio Analysis
NP Margin	-4.86	36.68	37.20	30.92	43.70	28.27	68.80	10.59	-6.58	-54.06	-23.46%
YoY %	-113.25%	-1.40%	20.31%	-29.24%	54.58%	-58.91%	549.67%	260.94%	87.83%	-	-
Horiz. %	8.99%	-67.85%	-68.81%	-57.20%	-80.84%	-52.29%	-127.27%	-19.59%	12.17%	100.00%	-

	31/12/24	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	CAGR
Per Share
EPS	-2.08	14.05	12.97	9.09	10.44	4.58	8.25	1.06	-0.46	-2.32	-1.20%
YoY %	-114.80%	8.33%	42.68%	-12.93%	127.95%	-44.48%	678.30%	330.43%	80.17%	-	-
Horiz. %	89.66%	-605.60%	-559.05%	-391.81%	-450.00%	-197.41%	-355.60%	-45.69%	19.83%	100.00%	-
EPS Diluted	-2.08	13.89	12.82	9.01	10.29	4.51	8.09	1.04	-0.46	-2.31	-1.15%
YoY %	-114.97%	8.35%	42.29%	-12.44%	128.16%	-44.25%	677.88%	326.09%	80.09%	-	-
Horiz. %	90.04%	-601.30%	-554.98%	-390.04%	-445.45%	-195.24%	-350.22%	-45.02%	19.91%	100.00%	-

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.

Discussions

Be the first to like this. Showing 0 of 0 comments

Latest Videos